How Long is Your Reading List? Brain Imaging in High-Volume Clinics: What we’re seeing, and what’s next.

Your TBR (AKA “to be read”) list may be pretty long if you’re a student, if you’re trying to keep up with the trends on Book Tok, or if you've just made a trip to your favorite local bookstore. Our two guests on this episode of the SNMMI podcasts also have extensive reading lists, but they’re not New York Times best sellers — they’re images of the human brain. Jake Dubroff and Derek Johnson both work in clinics that conduct amyloid and tau PET imaging at high volumes. The scans they’re reading give providers insight into what’s going on in the human brain, particularly when it comes to diagnosing Alzheimer’s and other neurodegenerative diseases.  But the use of the scans isn’t nearly as widespread as it could be, mainly due to implementation barriers. Even so, things seem to be changing, especially with the FDA's approval of FET that was only recently announced. To learn more about navigating the work that goes into reading scans, how clinics handle high volumes of patients, and the future role of nuclear medicine in brain imaging, tune into the discussion. Now streaming wherever you listen to podcasts!

This episode of the Podcast is sponsored by GE HealthCare.

Vizamyl Important Safety Information

PRODUCT INDICATIONS AND USE

VIZAMYL™(flutemetamol F 18 injection) is indicated for positron-emission tomography (PET) of the brain to estimate amyloid beta neuritic plaque density in adults with cognitive impairment for:

• Evaluation of Alzheimer's disease(AD) and other causes of cognitive decline
• Selection of patients who are indicated for amyloid beta-directed therapy as described in the prescribing of information of the therapeutic products.

CONTRAINDICATIONS

VIZAMYL is contraindicated in patients with a history of hypersensitivity reaction to VIZAMYL or polysorbate 80.

ADVERSE REACTIONS

The most commonly reported adverse reactions in clinical trials were flushing(2%), increased blood pressure(2%), headache nausea and dizziness(1%).

Postmarketing experience included anaphylactic reactions. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.

Prior to VIZAMYL administration, please read the full Prescribing Information for additional Important Safety Information: https://gehealthcare.com/vizamyl-pi 

Want more SNMMI content? Follow us on:

YouTube | Instagram | LinkedIn | Twitter/X

Want more SNMMI content? Follow us on:

YouTube | Instagram | LinkedIn | Twitter/X